PCM
RCPI

Parsons Capital Management’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Parsons Capital Management’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,328
Closed -$16K – 598
2015
Q1 		$16K Buy
6,328
+44
+0.7% +$173 ﹤0.01% 590
2014
Q4 		$28K Hold
6,284
– – ﹤0.01% 337
2014
Q3 		$44K Sell
6,284
-820
-12% -$8.1K 0.01% 339
2014
Q2 		$105K Buy
+7,104
New +$123K 0.01% 333

Other funds holding RCPI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Parsons Capital Management's RCPI Position: Q2 2015 in Review

Parsons Capital Management sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q2 2015, closing a stake of 6,328 shares — an estimated $16K sold.

Parsons Capital Management first reported a position in RCPI in Q2 2014 and held it in 4 quarters. The position peaked at $105K in Q2 2014. 36 funds tracked by Wall St. Rank hold RCPI as of Q2 2015.

  • Parsons Capital Management reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Parsons Capital Management sold 6,328 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $16K.
  • Parsons Capital Management first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 4 quarters.
  • Parsons Capital Management's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $105K in Q2 2014.
  • 36 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Parsons Capital Management's 13F filing for Q2 2015, filed 5 Aug 2015.